SQUAWK/NEWS
Account
Account
Menu
Live NewsCategoriesequity

Beam Therapeutics Inc. (BEAM) News

Track canonical SquawkNews coverage tagged to BEAM, Beam Therapeutics Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol BEAM Asset equity Sector Markets 90 days 1 Last 26.72 Updated Aug 04, 2026, 11:00 AM UTC Open live news feed
L BEAM - Beam Therapeutics Reports Second Quarter 2026 Financial Results and Announces First Patient Dosed in Global Pivotal Cohort of BEAM-30 BEAM - Beam Therapeutics Reports Second Quarter 2026 Financial Results and Announces First Patient Dosed in Global Pivotal Cohort of BEAM-302 Trial in Alpha-1 Antitrypsin Deficiency (AATD) EARNINGS | Aug 04, 2026, 11:00 AM UTC